
Vali oma silt
näidatakse otse viaalilLaboriaruanne
PDF- Testitud
- GHK-Cu + KPV Blend 60mg
- Labor
- Analiza Białek
- Kuupäev
- October 2026
- Tulemus
- 99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
- Endotoksiinid
- 6.88 EU/vial
- Tellimuse nr
- Parool
Sõltumatult testitud, kontrollitav parooliga otse laboris.
GHK-Cu + KPV Blend
Healing
- Laboris testitud · 99% puhtus
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
GHK-Cu + KPV Blend arvudes
Põhinäitajad meie leksikonist.
Täielik leksikoni artikkel- Type
- Blend of two tripeptidesGHK-Cu + KPV
- Use
- Subcutaneous injection after reconstitution
- Sizes
- 60 mg1 size in the shop
What studies show
All 7 sources in the lexicon- BioMed Research International
- Journal of Biomaterials Science, Polymer Edition
- Macromolecular Bioscience
Arvustused
Mida kliendid ütlevad
Ainult päris tellimused, milles oli GHK-Cu + KPV Blend.
Kõik arvustusedTeadmised
Kõik teemal GHK-Cu + KPV Blend
Üksikasjalik teave tuleb peagi.
Annustamine
Annustamisteabe laadimine …
Telli kohe kaasa
Mida sul sellega vaja on
Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.
Insuliinisüstlad
10 tk · 5.50 €
Alkoholilapid
50 tk · 10 €
Kui palju vett?
Ühikud süstlal sinu viaali suuruse jaoks.
Ava kalkulaator →Are there studies on the GHK-Cu + KPV Blend?
No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.
Why these two peptides?
The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.
What is known about GHK-Cu in humans?
The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.
What is known about KPV?
KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.
Which side effects are known?
There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.
Is the blend approved?
No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.
Seotud
Seotud tooted
BPC-157
Peptiidid · Paranemine ja taastumine Paranemine ja taastumine
4 suurust
Laboris testitud
= alates 5.2 €/viaal
TB-500 (Thymosin B4)
Peptiidid · Paranemine ja taastumine Paranemine ja taastumine
3 suurust
Laboris testitud
= alates 18.8 €/viaal
TB-500 FRAG
Peptiidid · Paranemine ja taastumine Paranemine ja taastumine
1 suurus
= 24.8 €/viaal
BPC + TB Blend
Peptiidid · Paranemine ja taastumine Paranemine ja taastumine
3 suurust
Laboris testitud
= alates 24.8 €/viaal
GHK-Cu + KPV Blend